2. Pathophysiology of Schizophrenia

  1. Wolfgang Gaebel
  1. Peter Falkai1,
  2. Andrea Schmitt2 and
  3. Tyrone D. Cannon3

Published Online: 13 APR 2011

DOI: 10.1002/9780470978672.ch2

Schizophrenia: Current Science and Clinical Practice

Schizophrenia: Current Science and Clinical Practice

How to Cite

Falkai, P., Schmitt, A. and Cannon, T. D. (2011) Pathophysiology of Schizophrenia, in Schizophrenia: Current Science and Clinical Practice (ed W. Gaebel), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470978672.ch2

Editor Information

  1. Heinrich-Heine University, Düsseldorf, Germany

Author Information

  1. 1

    Department of Psychiatry and Psychotherapy, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, Germany

  2. 2

    Department of Psychiatry, University of Göttingen, Von-Siebold-Str. 5, 37075 Göttingen, Germany

  3. 3

    Departments of Psychology and Psychiatry and Biobehavioral Sciences and Staglin, Center for Cognitive Neuroscience, University of California, Los Angeles, 1285 Franz Hall, Los Angeles, CA 90095-1563, USA

Publication History

  1. Published Online: 13 APR 2011
  2. Published Print: 1 APR 2011

Book Series:

  1. World Psychiatric Association Evidence and Experience in Psychiatry Series

Book Series Editors:

  1. Helen Herrman

Series Editor Information

  1. WPA Secretary for Publications, University of Melbourne, Australia

ISBN Information

Print ISBN: 9780470710548

Online ISBN: 9780470978672

SEARCH

Keywords:

  • Pathophysiology of schizophrenia;
  • Prepulse inhibition (PPI);
  • ‘dementia praecox’;
  • N-methyl-D-aspartate (NMDA);
  • gamma-butyric acid (GABA);
  • Positron Emission Tomography (PET);
  • D-amino-acid oxidase (DAAO);
  • magnetic resonance imaging (MRI);
  • cerebrospinal fluid (CSF)

Summary

This chapter contains sections titled:

  • Introduction

  • Major findings and related pathophysiological hypotheses

  • Summary and conclusions

  • References